I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 11 studies | 19% ± 5% | |
| type I pneumocyte | 7 studies | 27% ± 5% | |
| endothelial cell | 7 studies | 24% ± 7% | |
| ciliated cell | 6 studies | 25% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
| epithelial cell | 4 studies | 28% ± 5% | |
| GABAergic neuron | 4 studies | 41% ± 10% | |
| astrocyte | 4 studies | 20% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 5% | |
| interneuron | 4 studies | 34% ± 20% | |
| oligodendrocyte | 4 studies | 19% ± 2% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 3% | |
| capillary endothelial cell | 3 studies | 16% ± 1% | |
| plasma cell | 3 studies | 17% ± 1% | |
| glutamatergic neuron | 3 studies | 55% ± 8% | |
| adipocyte | 3 studies | 22% ± 4% |
